Bio-Techne
TECH
#1667
Rank
NZ$17.81 B
Marketcap
$112.71
Share price
1.55%
Change (1 day)
-7.36%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total assets

Total assets on the balance sheet as of December 2024 : NZ$4.67 Billion

According to Bio-Techne's latest financial reports the company's total assets are NZ$4.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Bio-Techne - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-06-30NZ$4.34 B17.99%
2022-06-30NZ$3.68 B13.86%
2021-06-30NZ$3.23 B2.63%
2020-06-30NZ$3.15 B12.53%
2019-06-30NZ$2.80 B19.16%
2018-06-30NZ$2.35 B10.36%
2017-06-30NZ$2.13 B34.44%
2016-06-30NZ$1.58 B1.98%
2015-06-30NZ$1.55 B58.2%
2014-06-30NZ$0.98 B-2.19%
2013-06-30NZ$1.00 B12.1%
2012-06-30NZ$0.89 B19.89%
2011-06-30NZ$0.74 B-1.22%
2010-06-30NZ$0.75 B3.55%
2009-06-30NZ$0.73 B9.76%
2008-06-30NZ$0.66 B12.55%
2007-06-30NZ$0.59 B-2.59%
2006-06-30NZ$0.60 B43.36%
2005-06-30NZ$0.42 B-17.43%
2004-06-30NZ$0.51 B13.46%
2003-06-30NZ$0.45 B-7.75%
2002-06-30NZ$0.49 B-7.53%
2001-06-30NZ$0.53 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$170.40 B 3,544.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$16.39 B 250.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$95.71 B 1,947.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$135.77 B 2,803.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.97 B 134.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$215.61 B 4,511.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.13 B-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA